Feasibility and safety study of apatinib mesylate in combination with s-1 for neoadjuvant treatment of colorectal cancer and postoperative management of s-1

ABSTRACT: Interventions: Case series:Preoperative apatinib combined with S-1, for the maintenance of postoperative S-1 Primary outcome(s): Total resection rate (R0 / R1 / R2);Two-year disease-free survival rate;Safty;PFS;PFS Study Design: Case series

DISEASE(S): Colorectal Cancer

PROVIDER: 2675770 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR